Breaking News

CPhI India Report Forecasts Growth Markets

Says Indian manufacturers evolving to high-value, low volume work and shifting R&D programs to the West

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CPhI Worldwide, organized by UBM Live, has released the findings of its Pharma Insights: India report providing an analysis of the India pharma market. Highlights from the report claim India’s biggest companies will see growth in contract research and manufacturing services (CRAMS) for patented products as trust in regulatory and quality standards increases. India will also see increasing clinical trial supply and advanced development work, according to the report.   Additionally, the report not...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters